Skip to main content
Erschienen in: Pediatric Nephrology 5/2012

01.05.2012 | Original Article

Clinical features and outcomes of 98 children and adults with dense deposit disease

verfasst von: Der-Fa Lu, Mikyung Moon, Lynne D. Lanning, Ann Marie McCarthy, Richard J. H. Smith

Erschienen in: Pediatric Nephrology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Dense deposit disease (DDD) is an ultra-rare renal disease.

Methods

In the study reported here, 98 patients and their families participated in a descriptive patient-centered survey using an online research format. Reports were completed by patients (38%) or their parents (62%). Age at diagnosis ranged from 1.9 to 38.9 years (mean 14 years).

Results

The majority of patients presented with proteinuria and hematuria; 50% had hypertension and edema. Steroids were commonly prescribed, although their use was not evidence-based. One-half of the patients with DDD for 10 years progressed to end-stage renal disease (ESRD), with young females having the greatest risk for renal failure. Of first allografts, 45% failed within 5 years, most frequently due to recurrent disease (70%). Type 1 diabetes (T1D) was present in over 16% of families, which represents a 116-fold increase in incidence compared with the general population (p < 0.001).

Conclusions

Based on these findings, we suggest that initiatives are needed to explore the high incidence of T1D in family members of DDD patients and the greater risk for progression to ESRD in young females with DDD. These efforts must be supported by sufficient numbers of patients to establish evidence-based practice guidelines for disease management. An international collaborative research survey should be implemented to encourage broad access and participation.
Literatur
1.
Zurück zum Zitat Nasr S, Valeri A, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD (2009) Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol 4:22–32PubMedCrossRef Nasr S, Valeri A, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD (2009) Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol 4:22–32PubMedCrossRef
2.
Zurück zum Zitat Strobel S, Zimmering M, Papp K, Prechl J, Jozsi M (2010) Anti-factor B autoantibody in dense deposit disease. Mol Immunol 47:1476–1483PubMedCrossRef Strobel S, Zimmering M, Papp K, Prechl J, Jozsi M (2010) Anti-factor B autoantibody in dense deposit disease. Mol Immunol 47:1476–1483PubMedCrossRef
3.
Zurück zum Zitat Walker PD, Ferrario F, Joh K, Bonsib SM (2007) Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 20:605–616PubMedCrossRef Walker PD, Ferrario F, Joh K, Bonsib SM (2007) Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 20:605–616PubMedCrossRef
4.
Zurück zum Zitat Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group (2007) New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18:2447–2456CrossRef Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group (2007) New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18:2447–2456CrossRef
5.
6.
Zurück zum Zitat Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ (2011) Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6:1009–1017PubMedCrossRef Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ (2011) Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6:1009–1017PubMedCrossRef
7.
Zurück zum Zitat Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16:1392–1403PubMedCrossRef Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16:1392–1403PubMedCrossRef
9.
Zurück zum Zitat Misra A, Peethambaram A, Garg A (2004) Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83:18–34CrossRef Misra A, Peethambaram A, Garg A (2004) Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83:18–34CrossRef
10.
Zurück zum Zitat D'souza YB, Jones CJ, Short CD, Roberts IS, Bonshek RE (2009) Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II. Kidney Int 75:824–827PubMedCrossRef D'souza YB, Jones CJ, Short CD, Roberts IS, Bonshek RE (2009) Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II. Kidney Int 75:824–827PubMedCrossRef
12.
Zurück zum Zitat Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, Cook HT, Botto M (2006) Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci USA 103:9649–9654PubMedCrossRef Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, Cook HT, Botto M (2006) Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci USA 103:9649–9654PubMedCrossRef
13.
Zurück zum Zitat Ponticelli C, Glassock RJ (1997) Treatment of Primary Glomerulonephritis, 2nd edn. Oxford University Press, Oxford Ponticelli C, Glassock RJ (1997) Treatment of Primary Glomerulonephritis, 2nd edn. Oxford University Press, Oxford
14.
Zurück zum Zitat Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis Am J Med 74:175–192 Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis Am J Med 74:175–192
15.
Zurück zum Zitat Liu JC, Yang JY, Xiao HJ, Huang JP, Yao Y, Li X, Wang SX (2009) Clinical and pathological characteristics of children with dense deposit disease. Zhonghua Er Ke Za Zhi 47:593–597PubMed Liu JC, Yang JY, Xiao HJ, Huang JP, Yao Y, Li X, Wang SX (2009) Clinical and pathological characteristics of children with dense deposit disease. Zhonghua Er Ke Za Zhi 47:593–597PubMed
16.
Zurück zum Zitat Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, Tizard EJ, Hulton SA, Milford DV, Taylor CM (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant 19:2769–2777PubMedCrossRef Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, Tizard EJ, Hulton SA, Milford DV, Taylor CM (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant 19:2769–2777PubMedCrossRef
17.
Zurück zum Zitat Lu DF, McCarthy AM, Lanning LD, Delaney C, Porter C (2007) A descriptive study of individuals with membranoproliferative glomerulonephritis. Nephrol Nurs J 34:295–302, quiz 303PubMed Lu DF, McCarthy AM, Lanning LD, Delaney C, Porter C (2007) A descriptive study of individuals with membranoproliferative glomerulonephritis. Nephrol Nurs J 34:295–302, quiz 303PubMed
18.
Zurück zum Zitat Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ (2006) Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69:504–511PubMedCrossRef Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ (2006) Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69:504–511PubMedCrossRef
19.
Zurück zum Zitat Schwertz R, de Jong R, Gretz N, Kirschfink M, Anders D, Scharer K (1996) Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie. Acta Paediatr 85:308–312 Schwertz R, de Jong R, Gretz N, Kirschfink M, Anders D, Scharer K (1996) Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie. Acta Paediatr 85:308–312
20.
Zurück zum Zitat Braun MC, Stablein DM, Hamiwka LA, Bell L, Bartosh SM, Strife CF (2005) Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol 16:2225–2233PubMedCrossRef Braun MC, Stablein DM, Hamiwka LA, Bell L, Bartosh SM, Strife CF (2005) Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol 16:2225–2233PubMedCrossRef
21.
Zurück zum Zitat Dizdar O, Kahraman S, Gençtoy G, Ertoy D, Arici M, Altun B, Yasavul U, Turgan C (2004) Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto's thyroiditis. Nephrol Dial Transplant 19:988–989PubMedCrossRef Dizdar O, Kahraman S, Gençtoy G, Ertoy D, Arici M, Altun B, Yasavul U, Turgan C (2004) Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto's thyroiditis. Nephrol Dial Transplant 19:988–989PubMedCrossRef
22.
Zurück zum Zitat Srikanta S, Malaviya AN, Rajagopalan P, Bhuyan UN, Ahuja MM (1983) Association of type I (insulin-dependent) diabetes mellitus, autoimmunity, antinuclear antibody, and membranoproliferative glomerulonephritis. Diabetes Care 6:71–74PubMedCrossRef Srikanta S, Malaviya AN, Rajagopalan P, Bhuyan UN, Ahuja MM (1983) Association of type I (insulin-dependent) diabetes mellitus, autoimmunity, antinuclear antibody, and membranoproliferative glomerulonephritis. Diabetes Care 6:71–74PubMedCrossRef
23.
Zurück zum Zitat Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, Li Y, Sarwar R, Langley SR, Bauerfeind A, Hummel O, Lee YA, Paskas S, Rintisch C, Saar K, Cooper J, Buchan R, Gray EE, Cyster JG; Cardiogenics Consortium, Erdmann J, Hengstenberg C, Maouche S, Ouwehand WH, Rice CM, Samani NJ, Schunkert H, Goodall AH, Schulz H, Roider HG, Vingron M, Blankenberg S, Münzel T, Zeller T, Szymczak S, Ziegler A, Tiret L, Smyth DJ, Pravenec M, Aitman TJ, Cambien F, Clayton D, Todd JA, Hubner N, Cook SA (2010) A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467:460–464CrossRef Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, Li Y, Sarwar R, Langley SR, Bauerfeind A, Hummel O, Lee YA, Paskas S, Rintisch C, Saar K, Cooper J, Buchan R, Gray EE, Cyster JG; Cardiogenics Consortium, Erdmann J, Hengstenberg C, Maouche S, Ouwehand WH, Rice CM, Samani NJ, Schunkert H, Goodall AH, Schulz H, Roider HG, Vingron M, Blankenberg S, Münzel T, Zeller T, Szymczak S, Ziegler A, Tiret L, Smyth DJ, Pravenec M, Aitman TJ, Cambien F, Clayton D, Todd JA, Hubner N, Cook SA (2010) A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467:460–464CrossRef
24.
Zurück zum Zitat Holcomb CL, Hoglund B, Anderson MW, Blake LA, Böhme I, Egholm M, Ferriola D, Gabriel C, Gelber SE, Goodridge D, Hawbecker S, Klein R, Ladner M, Lind C, Monos D, Pando MJ, Pröll J, Sayer DC, Schmitz-Agheguian G, Simen BB, Thiele B, Trachtenberg EA, Tyan DB, Wassmuth R, White S, Erlich HA (2011) A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens 77:206–217PubMedCrossRef Holcomb CL, Hoglund B, Anderson MW, Blake LA, Böhme I, Egholm M, Ferriola D, Gabriel C, Gelber SE, Goodridge D, Hawbecker S, Klein R, Ladner M, Lind C, Monos D, Pando MJ, Pröll J, Sayer DC, Schmitz-Agheguian G, Simen BB, Thiele B, Trachtenberg EA, Tyan DB, Wassmuth R, White S, Erlich HA (2011) A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens 77:206–217PubMedCrossRef
25.
Zurück zum Zitat Leung AK, Wong AH (2010) Proteinuria in children. Am Fam Physician 82:645–651PubMed Leung AK, Wong AH (2010) Proteinuria in children. Am Fam Physician 82:645–651PubMed
26.
Zurück zum Zitat Kalaitzidis R, Bakris GL (2009) Effects of angiotensin II receptor blockers on diabetic nephropathy. J Hypertens Suppl 27:S15–S21PubMedCrossRef Kalaitzidis R, Bakris GL (2009) Effects of angiotensin II receptor blockers on diabetic nephropathy. J Hypertens Suppl 27:S15–S21PubMedCrossRef
27.
Zurück zum Zitat Galle J (2008) Reduction of proteinuria with angiotensin receptor blockers. Nat Clin Pract Cardiovasc Med 5[Suppl 1]:S36–S43PubMedCrossRef Galle J (2008) Reduction of proteinuria with angiotensin receptor blockers. Nat Clin Pract Cardiovasc Med 5[Suppl 1]:S36–S43PubMedCrossRef
28.
Zurück zum Zitat Alchi B, Jayne D (2010) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25:1409–1418PubMedCrossRef Alchi B, Jayne D (2010) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25:1409–1418PubMedCrossRef
29.
Zurück zum Zitat Donadio JV Jr, Offord KP (1989) Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis. Am J Kidney Dis 14:445–451PubMed Donadio JV Jr, Offord KP (1989) Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis. Am J Kidney Dis 14:445–451PubMed
30.
Zurück zum Zitat West CD (1992) Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol 6:96–103PubMedCrossRef West CD (1992) Idiopathic membranoproliferative glomerulonephritis in childhood. Pediatr Nephrol 6:96–103PubMedCrossRef
31.
Zurück zum Zitat Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM (2010) Aging of the innate immune system. Curr Opin Immunol 22:507–513PubMedCrossRef Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM (2010) Aging of the innate immune system. Curr Opin Immunol 22:507–513PubMedCrossRef
32.
Zurück zum Zitat Gameiro C, Romao F (2010) Changes in the immune system during menopause and aging. Front Biosci (Elite Ed) 2:1299–1303CrossRef Gameiro C, Romao F (2010) Changes in the immune system during menopause and aging. Front Biosci (Elite Ed) 2:1299–1303CrossRef
33.
Zurück zum Zitat Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC (2010) Sex hormones and autoimmunity. Immunol Lett 133:6–13PubMedCrossRef Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC (2010) Sex hormones and autoimmunity. Immunol Lett 133:6–13PubMedCrossRef
34.
Zurück zum Zitat Riaño-Galán I, Málaga S, Rajmil L, Ariceta G, Navarro M, Loris C, Vallo A (2009) Quality of life of adolescents with end-stage renal disease and kidney transplant. Pediatr Nephrol 24:1561–1568PubMedCrossRef Riaño-Galán I, Málaga S, Rajmil L, Ariceta G, Navarro M, Loris C, Vallo A (2009) Quality of life of adolescents with end-stage renal disease and kidney transplant. Pediatr Nephrol 24:1561–1568PubMedCrossRef
35.
Zurück zum Zitat Pradel FG, Jain R, Mullins CD, Vassalotti JA, Bartlett ST (2008) A survey of nephrologists’ views on preemptive transplantation. Clin J Am Soc Nephrol 3:1837–1845PubMedCrossRef Pradel FG, Jain R, Mullins CD, Vassalotti JA, Bartlett ST (2008) A survey of nephrologists’ views on preemptive transplantation. Clin J Am Soc Nephrol 3:1837–1845PubMedCrossRef
36.
Zurück zum Zitat Boehm M, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C (2010) Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child 95:634–638PubMedCrossRef Boehm M, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C (2010) Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child 95:634–638PubMedCrossRef
37.
Zurück zum Zitat Davis CL (2010) Preemptive transplantation and the transplant first initiative. Curr Opin Nephrol Hypertens 19:592–597PubMedCrossRef Davis CL (2010) Preemptive transplantation and the transplant first initiative. Curr Opin Nephrol Hypertens 19:592–597PubMedCrossRef
38.
Zurück zum Zitat U.S. Renal Data System (2009) USRDS 2009 annual data report: atlas of end-stage renal disease in the United States. National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda U.S. Renal Data System (2009) USRDS 2009 annual data report: atlas of end-stage renal disease in the United States. National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
40.
Zurück zum Zitat Iitaka K, Igarashi S, Sakai T (1994) Hypocomplementaemia and membranoproliferative glomerulonephritis in school urinary screening in Japan. Pediatr Nephrol 8:420–422PubMedCrossRef Iitaka K, Igarashi S, Sakai T (1994) Hypocomplementaemia and membranoproliferative glomerulonephritis in school urinary screening in Japan. Pediatr Nephrol 8:420–422PubMedCrossRef
Metadaten
Titel
Clinical features and outcomes of 98 children and adults with dense deposit disease
verfasst von
Der-Fa Lu
Mikyung Moon
Lynne D. Lanning
Ann Marie McCarthy
Richard J. H. Smith
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 5/2012
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-2059-7

Weitere Artikel der Ausgabe 5/2012

Pediatric Nephrology 5/2012 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.